secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001213900-22-067174
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics gets Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------------

- Received Nasdaq letter on Oct 25, 2022 for non-compliance with minimum bid price rule (NASDAQ 5550(a)(2)).
- Closing bid price below $1.00 for 30 consecutive business days; 180-day cure period ends April 24, 2023.
- To regain compliance, bid price must close at $1.00 or higher for at least 10 consecutive business days.
- If not cured, may be eligible for additional 180 days if meeting other listing standards; otherwise subject to delisting.
- Company intends to take all reasonable measures to regain compliance but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390022067174/0001213900-22-067174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390022067174/ea167648-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-067174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer